Provider
P8-25 Update to Reimbursement Policy: Commercial General Coding 074 Cellular and Gene Therapy Product
Program effective Date: Feb 03, 2025
Search Results
Displaying 3471 - 3480 of 3651 results
Provider
2025 February Bulletins
Program effective Date: Feb 03, 2025
Financial Information
Provider
Commercial Reimbursement Policy Intraoperative Neurophysiological Monitoring (IONM)
Shopping & Learning
2025 Medicare Step-by-Step Guide
Provider
QP15-22 Commercial Pharmacy Benefit Update – Revised Drug-Related Prior Authorization (PA) Requirement Notification – Effective April 14, 2022
Program effective Date: Feb 23, 2022
Provider
QP66-22 Commercial Pharmacy Benefit Exclusion for Amvuttra™ and Skyrizi®
Program effective Date: Aug 10, 2022
Provider
QP86-22 MHCP Pharmacy Benefit Update: New drug-related Prior Authorization (PA) Criteria: Vtama® (tapinarof)
Program effective Date: Oct 26, 2022
Provider
QP13-23 Commercial Pharmacy Benefit Exclusion for Cinryze®, Kalbitor®, Leqembi™, and Nexobrid®
Program effective Date: Mar 08, 2023
Provider
QP12-22 MHCP Pharmacy Benefit Exclusion for Apretude, Tezspire™ and Vyvgart™
Program effective Date: Feb 09, 2022